• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Seres Therapeutics - Articles and news items

ecobiotics

Nestlé Health Science and Seres collaborate on Ecobiotics

Industry news / 12 January 2016 / Victoria White

Nestlé Health Science has signed an exclusive agreement outside the US and Canada for Seres Therapeutics’ Ecobiotics in clostridium difficile infections and inflammatory bowel disease…

clostridium-difficile-ser-109

First patient dosed in the Phase 2 study of SER-109 in recurrent Clostridium difficile infection

Industry news / 28 May 2015 / Victoria White

Seres Therapeutics has enrolled and dosed the first patient in its Phase 2 clinical study of SER-109 in recurrent CDI in adults…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionWATCH NOW
+ +